Journal article
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database
Abstract
Several systems (tumor-node-metastasis [TNM], Barcelona Clinic Liver Cancer [BCLC], Okuda, Cancer of the Liver Italian Program [CLIP], and albumin-bilirubin grade [ALBI]) were developed to estimate the prognosis of patients with hepatocellular carcinoma (HCC) mostly prior to the prevalent use of sorafenib. We aimed to compare the prognostic and discriminatory power of these models in predicting survival for HCC patients treated with sorafenib …
Authors
Samawi HH; Sim H; Chan KK; Alghamdi MA; Lee‐Ying RM; Knox JJ; Gill P; Romagnino A; Batuyong E; Ko Y
Journal
Cancer Medicine, Vol. 7, No. 7, pp. 2816–2825
Publisher
Wiley
Publication Date
July 2018
DOI
10.1002/cam4.1493
ISSN
2045-7634